MedPath

Comparison of Energy Instruments and Stapling Device to Dissect Intersegmental Plane in Segmentectomy

Not Applicable
Terminated
Conditions
Segmentectomy
Interventions
Device: Energy Instruments
Device: Stapling Device
Registration Number
NCT03192904
Lead Sponsor
Ruijin Hospital
Brief Summary

According to published studies, there are two main approaches in the dissection of intersegmental plane: stapling devices and energy instrument separation. However, only a few retrospective studies focused on the perioperative outcomes of these two approaches, and there has been no definitive conclusion about which method is better. So the investigators want to conduct a prospective study, trying to figure out this problem.

Detailed Description

Lung cancer has been one of the most serious life-threatening diseases of human society. It has the highest morbidity and mortality worldwide among all the malignant tumors. Due to the popularization of low-dose CT and other means of examination, more and more patients with lung cancer are detected in the early phase of disease. Anatomical segmentectomy is one of the standard surgical procedures for these small pulmonary nodules or ground glass opacity (GGO), which are clinically highly suspected or puncture confirmed early lung cancer lesions. Dissection of the intersegmental plane in segmentectomy is a difficulty that have puzzled thoracic surgeons for decades because of the complicated anatomic relationship and variations, along with lack of boundary between pulmonary segments. There are two main approaches in the dissection of intersegmental plane: stapling devices and energy instrument separation. However, only a few retrospective studies focused on the perioperative outcomes of these two approaches in segmentectomy, not to mention in robot assisted segmentectomy, and there has been no definitive conclusion about which method is better. So the investigators want to conduct a prospective study, trying to figure out this problem.

The investigators set incidence rate of postoperative complications as their primary endpoint. According to their calculation, a total of 136 patients will be enrolled (each group has 68 patients).

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
70
Inclusion Criteria
    1. Age: 18 to 70 years old; 2. Pulmonary nodules or GGO found in chest CT examination, and conform with indications for segmentectomy mentioned in NCCN guidelines:

    2. Poor pulmonary reserve or other major comorbidity that contraindicates lobectomy;

    3. Peripheral nodule ≤2 cm with at least one of the following:

    <!-- -->
    1. Pure (Adenocarcinoma in situ) AIS histology;

    2. Nodule has ≥50% ground-glass appearance on CT;

    3. Radiologic surveillance confirms a long doubling time (≥400 days). 3. Normal in preoperative tests, such as blood routine examination, liver function, renal function, coagulation function, etc.

    4. ASA score: Grade I-III. 5. Patients who can coordinate the treatment and research and sign the informed consent.

Exclusion Criteria
    1. Patients have history of malignant tumor, or have accepted neoadjuvant chemotherapy and(or) radiotherapy.

    2. Patients have comorbidities in cardiovascular, kidney, lung or hematopoietic system, who cannot tolerate the surgery.

    3. Psychiatric patients。 4. Patient have history of chest trauma or surgery on ipsilateral chest.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Energy Instruments GroupEnergy InstrumentsAll enrolled patients will accept robot-assisted or uniportal segmentectomy. After cutting off the relevant segmental arteries and veins, we clamp the segmental bronchus, and then the diseased lung will be ventilated to identify the border of segment according to the collapse region. We use energy instruments dissect intersegmental plane along the determined border. If fast-frozen pathology confirms lung cancer, we will do lymphadenectomy. At last, a drainage tube will be placed.
Stapling Device GroupStapling DeviceAll enrolled patients will accept robot-assisted or uniportal segmentectomy. After cutting off the relevant segmental arteries and veins, we clamp the segmental bronchus, and then the diseased lung will be ventilated to identify the border of segment according to the collapse region. We use stapling device to dissect intersegmental plane along the determined border. If fast-frozen pathology confirms lung cancer, we will do lymphadenectomy. At last, a drainage tube will be placed.
Primary Outcome Measures
NameTimeMethod
Incidence of Postoperative Complicationspostoperative in-hospital stay up to 30 days

The primary outcome was the incidence of postoperative complications, including air leakage (defined as a rate of air flow \>50 mL/min lasting more than 3 days), atelectasis (visible on chest X-rays with complaints), hemorrhage (bloody drainage more than 200 mL for 3 consecutive hours), pulmonary infection (visible on chest X-rays with complaint), and pulmonary embolism (confirmed by CT scan).

Secondary Outcome Measures
NameTimeMethod
Number of ConversionsDuring surgery

Proportion of converting to thoracotomy。

Incidence Rates of Each Postoperative Complicationspostoperative in-hospital stay up to 30 days
Preoperative Lung FunctionBaseline.
Postoperative Lung Function at the 3rd Month After Surgeryat the 3rd month after surgery
Postoperative Hospital Stayup to 24 weeks
Postoperative ICU Stayup to 24 weeks
Duration of Drainageup to 4 weeks
Drainage Volume of the First Day After SurgeryFirst day after surgery

The duration of chest drainage was different, so we analyzed the drainage volume the first day after surgery of each patient.

Daily Air Leakage VolumeDuring drainage time, up to 4 weeks
Blood Loss During SurgeryDuring surgery
Participants With Malignant Tumors2 weeks after surgery
Medical CostsDuring hospital stay, up to 24 weeks
Mortality in 30 Days After Surgerypostoperative in-hospital stay up to 30 days
Duration of SurgeryDuring surgery

Trial Locations

Locations (1)

Ruijin Hospital, Shanghai JiaoTong University School of Medicine

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath